CWS Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
CWS Financial Advisors's BMY Position: Q2 2025 in Review
CWS Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,357 shares — an estimated $205K sold.
CWS Financial Advisors first reported a position in BMY in Q4 2019 and held it in 17 quarters. The position peaked at $841K in Q2 2022. 2,298 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- CWS Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- CWS Financial Advisors sold 3,357 Bristol-Myers Squibb shares in Q2 2025, an estimated $205K.
- CWS Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 17 quarters.
- CWS Financial Advisors's Bristol-Myers Squibb position peaked at $841K in Q2 2022.
- 2,298 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on CWS Financial Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.